Antibody assets to be developed for cancer treatment
29 March, 2016Shares in Patrys rose almost 30% as the company announced that it will develop and commercialise as anticancer agents a portfolio of preclinical novel anti-DNA antibodies and antibody fragments/variants discovered at Yale University.
Phase IIb Parkinson's trial approved
24 March, 2016Living Cell Technologies has received approval from the Auckland Hospital Research Review Committee for its Phase IIb clinical trial of NTCELL for Parkinson's disease.
$20m in financing for blood-based bowel cancer test
23 March, 2016OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer.
Dedicated cancer research centre opening soon
16 March, 2016The Centenary Institute and the ACRF have announced the first dedicated cancer research centre in the RPA Hospital and University of Sydney precinct.
Positive data from bladder cancer trial
15 March, 2016Viralytics announced positive data from a clinical trial of its lead drug candidate, CAVATAK, at the 31st Annual European Association of Urology Congress held in Munich.
The protein that keeps cancer cells alive
08 March, 2016Researchers from the Walter and Eliza Hall Institute have discovered a protein that is key to the development of blood cancers caused by a common genetic error.
The mechanism behind neurodegeneration
07 March, 2016Researchers claim that a previously undiscovered mechanism in a key group of neurons affected in a neurodegenerating brain is the driver of the continuing cycle of neuronal cell death.
Australian-developed bowel cancer test approved in China
04 March, 2016Clinical Genomics has received China Food and Drug Administration approval for the commercialisation of InSure FIT, its faecal immunochemical test for colorectal cancer.
Partnership to fight prostate cancer
02 March, 2016Two key players in the fight against prostate cancer have announced that they will work together to fund and implement vital clinical trials into the disease.
Two-pronged treatment for blood cancer
01 March, 2016A research team has found that treatment of acute myeloid leukaemia — the most deadly form of blood cancer — may be improved by combining two recently developed drugs.
Pancreatic cancer is actually four different diseases
29 February, 2016An international research team has discovered that pancreatic cancer is actually four separate diseases with different genetic triggers and survival rates.
Pitch your innovative health product idea
25 February, 2016ide Group will be awarding $25,000 worth of product design and development support for the best health innovation product idea pitched at Building Better Futures for Health: A Product Design Challenge.
ImmunID and MSK sign master collaboration agreement
25 February, 2016ImmunID, a French company that seeks to personalise immunotherapy for cancer patients, has signed a master collaboration agreement with the world's oldest and largest private cancer centre.
Blood cancer drug's secret solved
24 February, 2016Researchers from the Walter and Eliza Hall Institute have solved a mystery about how a promising new class of anticancer drugs works.
Two new prostate cancer trials funded
23 February, 2016Prostate Cancer Foundation Australia (PCFA) and the Movember Foundation are funding two new clinical trials that will potentially revolutionise the way prostate cancers are monitored and treated.
